{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:20:36Z","timestamp":1792182036670,"version":"4.4.0"},"reference-count":175,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wroclaw Medical University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The increasing incidence of hospital-acquired infections and antimicrobial-resistant pathogens poses a major clinical challenge. Nearly all medical devices are vulnerable to bacterial biofilm formation, which acts as a protective coating against the host defense systems and antibiotics. The persistence of biofilm infections, accounting for around 65% of all microbial infections, and poor conventional treatment outcomes has driven interest in alternative approaches like bacteriophage therapy. This review encompasses key aspects of biofilm biology, taking into account the clinically significant ESKAPE pathogens, and provides an in-depth analysis of the role of phage agents in biofilm control as a new biofilm control strategy. Diving deeper into the mechanisms of phage-mediated processes, the review examines how bacteriophages penetrate and disrupt biofilm architecture and evaluates current therapeutic strategies that exploit these actions, acknowledging their limitations and considering possible future directions.<\/jats:p>","DOI":"10.3390\/ijms26178699","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:27:12Z","timestamp":1757500032000},"page":"8699","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Bacteriophage-Based Approach Against Biofilm Infections Associated with Medical Devices: A Narrative Review of ESKAPE Pathogens"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1297-5958","authenticated-orcid":false,"given":"Karolina","family":"Paw\u0142uszkiewicz","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 1, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6014-9589","authenticated-orcid":false,"given":"Tomasz","family":"Bus\u0142owicz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 1, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matylda","family":"Korgiel","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 1, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2881-6553","authenticated-orcid":false,"given":"Anita","family":"Faltus","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 1, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9100-9321","authenticated-orcid":false,"given":"Emilia","family":"Kucharczyk","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, Wybrze\u017ce L. Pasteura 1, 50-367 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Por\u0119bska","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-5705","authenticated-orcid":false,"given":"Pawe\u0142","family":"Pochcia\u0142","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6531-9787","authenticated-orcid":false,"given":"Natalia","family":"Kucharczyk","sequence":"additional","affiliation":[{"name":"Health Care Complex in O\u0142awa, ul. Baczy\u0144skiego 1, 55-200 O\u0142awa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-6136","authenticated-orcid":false,"given":"Emil","family":"Paluch","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, St. T. Cha\u0142ubi\u0144skiego 4, 50-376 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2011). Report on the Burden of Endemic Health Care-Associated Infection Worldwide Clean Care Is Safer Care."},{"key":"ref_2","unstructured":"World Health Organization (2024). Global Report on Infection Prevention and Control 2024 Executive Summary."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bit.21838","article-title":"Medical Biofilms","volume":"100","author":"Bryers","year":"2008","journal-title":"Biotechnol. Bioeng."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/SHK.0000000000000692","article-title":"Implantable Device Related Infection","volume":"46","author":"Younger","year":"2016","journal-title":"Shock"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wyss, U.P. (2019). Improving the Quality of Life of Patients with Medical Devices by a Timely Analysis of Adverse Events. Front. Med., 6.","DOI":"10.3389\/fmed.2019.00056"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Yasir, M., Willcox, M.D.P., and Dutta, D. (2018). Action of Antimicrobial Peptides against Bacterial Biofilms. Materials, 11.","DOI":"10.3390\/ma11122468"},{"key":"ref_7","first-page":"100175","article-title":"Biofilm-Forming Microorganisms Causing Hospital-Acquired Infections from Intravenous Catheter: A Systematic Review","volume":"3","author":"Reyes","year":"2022","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bouhrour, N., Nibbering, P.H., and Bendali, F. (2024). Medical Device-Associated Biofilm Infections and Multidrug-Resistant Pathogens. Pathogens, 13.","DOI":"10.3390\/pathogens13050393"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s42770-021-00624-x","article-title":"Microbial Biofilm: Formation, Architecture, Antibiotic Resistance, and Control Strategies","volume":"52","author":"Rather","year":"2021","journal-title":"Braz. J. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Reffuveille, F., Dghoughi, Y., Colin, M., Torres, M.D.T., and de la Fuente-Nunez, C. (2024). Antibiofilm Approaches as a New Paradigm for Treating Infections. Prog. Biomed. Eng., 6.","DOI":"10.1088\/2516-1091\/ad1cd6"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sharma, S., Mohler, J., Mahajan, S.D., Schwartz, S.A., Bruggemann, L., and Aalinkeel, R. (2023). Microbial Biofilm: A Review on Formation, Infection, Antibiotic Resistance, Control Measures, and Innovative Treatment. Microorganisms, 11.","DOI":"10.3390\/microorganisms11061614"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.3390\/ijms140918488","article-title":"Novel Strategies for the Prevention and Treatment of Biofilm Related Infections","volume":"14","author":"Chen","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_13","unstructured":"Agarwal, A., Kelkar, A., Agarwal, A.G., Jayaswal, D., Schultz, C., Jayaswal, A., Goel, V.K., Agarwal, A.K., and Gidvani, S. (2021). Novel Approaches to Combat Medical Device-Associated BioFilms. Coatings, 11."},{"key":"ref_14","unstructured":"World Health Organization (2017). Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2024.10.021","article-title":"Indwelling Urological Device Biofilm Composition and Characteristics in the Presence and Absence of Infection","volume":"196","author":"Werneburg","year":"2025","journal-title":"Urology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e01067","DOI":"10.1016\/j.heliyon.2018.e01067","article-title":"Bacterial Biofilm Formation on Implantable Devices and Approaches to Its Treatment and Prevention","volume":"4","author":"Khatoon","year":"2018","journal-title":"Heliyon"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e02071-21","DOI":"10.1128\/aac.02071-21","article-title":"Considerations for the Use of Phage Therapy in Clinical Practice","volume":"66","author":"Suh","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Abraham, W.R. (2016). Going beyond the Control of Quorum-Sensing to Combat Biofilm Infections. Antibiotics, 5.","DOI":"10.3390\/antibiotics5010003"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e02192","DOI":"10.1016\/j.heliyon.2019.e02192","article-title":"Challenges of Intervention, Treatment, and Antibiotic Resistance of Biofilm-Forming Microorganisms","volume":"5","author":"Gebreyohannes","year":"2019","journal-title":"Heliyon"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00253-020-10349-w","article-title":"Prevention of Biofilm Formation by Quorum Quenching","volume":"104","author":"Paluch","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/antibiotics3030270","article-title":"Bacteriophages and Biofilms","volume":"3","author":"Harper","year":"2014","journal-title":"Antibiotics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/MMBR.00069-15","article-title":"Genetically Engineered Phages: A Review of Advances over the Last Decade","volume":"80","author":"Pires","year":"2016","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1365-2958.2005.05008.x","article-title":"A Characterization of DNA Release in Pseudomonas aeruginosa Cultures and Biofilms","volume":"59","author":"Barken","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The Biofilm Matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lembre, P., Lorentz, C., and Di, P. (2012). Exopolysaccharides of the Biofilm Matrix: A Complex Biophysical World. The Complex World of Polysaccharides, InTech.","DOI":"10.5772\/51213"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/microbiolspec.MB-0011-2014","article-title":"Bacterial Extracellular Polysaccharides in Biofilm Formation and Function","volume":"3","author":"Limoli","year":"2015","journal-title":"Microbiol. Spectr."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Mann, E.E., Rice, K.C., Boles, B.R., Endres, J.L., Ranjit, D., Chandramohan, L., Tsang, L.H., Smeltzer, M.S., Horswill, A.R., and Bayles, K.W. (2009). Modulation of EDNA Release and Degradation Affects Staphylococcus Aureus Biofilm Maturation. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005822"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/1040841X.2013.841639","article-title":"The Role of Extracellular DNA in the Establishment, Maintenance and Perpetuation of Bacterial Biofilms","volume":"41","author":"Okshevsky","year":"2015","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.00043-12","article-title":"Cyclic Di-GMP: The First 25 Years of a Universal Bacterial Second Messenger","volume":"77","author":"Galperin","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-med-042711-140023","article-title":"Staphylococcal Infections: Mechanisms of Biofilm Maturation and Detachment as Critical Determinants of Pathogenicity","volume":"64","author":"Otto","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/MMBR.00013-14","article-title":"Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics","volume":"78","author":"Lebeaux","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/mmi.13634","article-title":"Staphylococcus aureus Biofilm: A Complex Developmental Organism","volume":"104","author":"Moormeier","year":"2017","journal-title":"Mol. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Otto, M. (2018). Staphylococcal Biofilms. Microbiol. Spectr., 6.","DOI":"10.1128\/microbiolspec.GPP3-0023-2018"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/viru.2.5.17724","article-title":"Staphylococcus Aureus Biofilms: Properties, Regulation and Roles in Human Disease","volume":"2","author":"Archer","year":"2011","journal-title":"Virulence"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"20983","DOI":"10.3390\/ijms141020983","article-title":"Biofilm Matrix and Its Regulation in Pseudomonas aeruginosa","volume":"14","author":"Wei","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1128\/AEM.00637-11","article-title":"Role of Exopolysaccharides in Pseudomonas aeruginosa Biofilm Formation and Architecture","volume":"77","author":"Ghafoor","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Desai, S., Sanghrajka, K., and Gajjar, D. (2019). High Adhesion and Increased Cell Death Contribute to Strong Biofilm Formation in Klebsiella pneumoniae. Pathogens, 8.","DOI":"10.3390\/pathogens8040277"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Schroll, C., Barken, K.B., Krogfelt, K.A., and Struve, C. (2010). Role of Type 1 and Type 3 Fimbriae in Klebsiella pneumoniae Biofilm Formation. BMC Microbiol., 10.","DOI":"10.1186\/1471-2180-10-179"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2147\/IDR.S332051","article-title":"Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review","volume":"14","author":"Gedefie","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Ramos-Vivas, J., Chapartegui-Gonz\u00e1lez, I., Fern\u00e1ndez-Mart\u00ednez, M., Gonz\u00e1lez-Rico, C., Fort\u00fan, J., Escudero, R., Marco, F., Linares, L., Montejo, M., and Aranzamendi, M. (2019). Biofilm Formation by Multidrug Resistant Enterobacteriaceae Strains Isolated from Solid Organ Transplant Recipients. Sci. Rep., 9.","DOI":"10.3389\/fcimb.2020.00447"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Cie\u015blik, M., W\u00f3jcicki, M., Migda\u0142, P., Grygiel, I., Bajrak, O., Orwat, F., G\u00f3rski, A., and Jo\u0144czyk-Matysiak, E. (2025). Fighting Biofilm: Bacteriophages Eliminate Biofilm Formed by Multidrug-Resistant Enterobacter Hormaechei on Urological Catheters. Med. Microbiol. Immunol., 214.","DOI":"10.1007\/s00430-025-00844-0"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1078\/1438-4221-00196","article-title":"Mechanisms of Antibiotic Resistance in Bacterial Biofilms","volume":"292","author":"Stewart","year":"2002","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/femsre\/fux010","article-title":"Molecular Mechanisms of Biofilm-Based Antibiotic Resistance and Tolerance in Pathogenic Bacteria","volume":"41","author":"Hall","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrmicro1557","article-title":"Persister Cells, Dormancy and Infectious Disease","volume":"5","author":"Lewis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2014.80","article-title":"Persisters, Persistent Infections and the Yin-Yang Model","volume":"3","author":"Zhang","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Grooters, K.E., Ku, J.C., Richter, D.M., Krinock, M.J., Minor, A., Li, P., Kim, A., Sawyer, R., and Li, Y. (2024). Strategies for Combating Antibiotic Resistance in Bacterial Biofilms. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1352273"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic Resistance of Bacterial Biofilms","volume":"35","author":"Bjarnsholt","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1073\/pnas.1804084115","article-title":"New Insight into the Early Stages of Biofilm Formation","volume":"115","author":"Armbruster","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Muhammad, M.H., Idris, A.L., Fan, X., Guo, Y., Yu, Y., Jin, X., Qiu, J., Guan, X., and Huang, T. (2020). Beyond Risk: Bacterial Biofilms and Their Regulating Approaches. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00928"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09168451.2015.1058701","article-title":"Environmental Factors That Shape Biofilm Formation","volume":"80","author":"Toyofuku","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","article-title":"Targeting Microbial Biofilms: Current and Prospective Therapeutic Strategies","volume":"15","author":"Koo","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Mishra, A., Aggarwal, A., and Khan, F. (2024). Medical Device-Associated Infections Caused by Biofilm-Forming Microbial Pathogens and Controlling Strategies. Antibiotics, 13.","DOI":"10.3390\/antibiotics13070623"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcma.2017.07.012","article-title":"Bacterial Biofilm and Associated Infections","volume":"81","author":"Jamal","year":"2018","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1128\/JB.01655-07","article-title":"Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics","volume":"190","author":"Zhang","year":"2008","journal-title":"J. Bacteriol."},{"key":"ref_56","first-page":"1","article-title":"Bacterial Biofilm: Its Composition, Formation and Role in Human Infections","volume":"4","author":"Jamal","year":"2015","journal-title":"Res. Rev. J. Microbiol. Biotechnol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jobm.202000678","article-title":"Microbial Biofilm: A Matter of Grave Concern for Human Health and Food Industry","volume":"61","author":"Rather","year":"2021","journal-title":"J. Basic Microbiol."},{"key":"ref_58","first-page":"1454","article-title":"Tracking Antibiotic Resistance","volume":"345","author":"Beatson","year":"2014","journal-title":"Science (1979)"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Tiwari, V. (2023). ESKAPE Biofilm: Challenges and Solutions. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1253439"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Manandhar, S., Karn, D., Shrestha, M.R., Shakya, J., and Singh, A. (2025). Biofilm Formation, Methicillin Resistance and SCCmec Types among Staphylococcus Aureus Isolated from Clinical Samples from a Tertiary Care Hospital, in Nepal. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10943-1"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"McCarthy, H., Rudkin, J.K., Black, N.S., Gallagher, L., O\u2019Neill, E., and O\u2019Gara, J.P. (2015). Methicillin Resistance and the Biofilm Phenotype in Staphylococcus Aureus. Front. Cell. Infect. Microbiol., 5.","DOI":"10.3389\/fcimb.2015.00001"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","article-title":"Bacterial Flagellin Is a Dominant Antigen in Crohn Disease","volume":"113","author":"Lodes","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/MMBR.00030-07","article-title":"Molecular Control of Bacterial Death and Lysis","volume":"72","author":"Rice","year":"2008","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_64","first-page":"1318","article-title":"Bacterial Biofilms: A Common Cause of Persistent Infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science (1979)"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic Resistance in Pseudomonas aeruginosa: Mechanisms and Alternative Therapeutic Strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Chegini, Z., Khoshbayan, A., Taati Moghadam, M., Farahani, I., Jazireian, P., and Shariati, A. (2020). Bacteriophage Therapy against Pseudomonas aeruginosa Biofilms: A Review. Ann. Clin. Microbiol. Antimicrob., 19.","DOI":"10.1186\/s12941-020-00389-5"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1128\/AAC.00433-15","article-title":"Contribution of Stress Responses to Antibiotic Tolerance in Pseudomonas aeruginosa Biofilms","volume":"59","author":"Stewart","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Ciofu, O., and Tolker-Nielsen, T. (2019). Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents-How P. aeruginosa Can Escape Antibiotics. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00913"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Bill\u00f3n, M., Llamb\u00edas-Cabot, A.E., Jordana-Lluch, E., Oliver, A., and Maci\u00e0, M.D. (2023). Mechanisms of Antibiotic Resistance in Pseudomonas aeruginosa Biofilms. Biofilm, 5.","DOI":"10.1016\/j.bioflm.2023.100129"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jgar.2021.11.009","article-title":"Isolation of Persister Cells within the Biofilm and Relative Gene Expression Analysis of Type II Toxin\/Antitoxin System in Pseudomonas aeruginosa Isolates in Exponential and Stationary Phases","volume":"28","author":"Zadeh","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1574-695X.2012.00965.x","article-title":"Biofilm Formation of Klebsiella pneumoniae on Urethral Catheters Requires Either Type 1 or Type 3 Fimbriae","volume":"65","author":"Stahlhut","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_72","first-page":"193","article-title":"The Effect of Antimicrobial Peptide LL-37 on Biofilm Formation of Klebsiella pneumoniae Isolated from Catheter-Associated Urinary Tract Infection Patients","volume":"22","author":"Rifaat","year":"2023","journal-title":"Iraqi J. Biotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/infdis\/jiv319","article-title":"An Essential Role for Coagulase in Staphylococcus aureus Biofilm Development Reveals New Therapeutic Possibilities for Device-Related Infections","volume":"212","author":"Zapotoczna","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Tart, A.H., and Wozniak, D.J. (2008). Shifting Paradigms in Pseudomonas aeruginosa Biofilm Research. Bacterial Biofilms, Springer.","DOI":"10.1007\/978-3-540-75418-3_9"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13756-022-01112-z","article-title":"Tolerance of Biofilm of a Carbapenem-Resistant Klebsiella pneumoniae Involved in a Duodenoscopy-Associated Outbreak to the Disinfectant Used in Reprocessing","volume":"11","author":"Brunke","year":"2022","journal-title":"Antimicrob. Resist. Infect. Control."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/112972980400500101","article-title":"Emerging Role of Enterococcus spp. in Catheter-Related Infections: Biofilm Formation and Novel Mechanisms of Antibiotic Resistance","volume":"5","author":"Donelli","year":"2004","journal-title":"J. Vasc. Access"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Busch, A.W.U., and Montgomery, B.L. (2015). The Tryptophan-Rich Sensory Protein (TSPO) Is Involved in Stress-Related and Light-Dependent Processes in the Cyanobacterium Fremyella Diplosiphon. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.01393"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lu, H., Li, Z., Elbaz, A., and Ni, S.Q. (2023). Synergistic Action of Phages and Lytic Proteins with Antibiotics: A Combination Strategy to Target Bacteria and Biofilms. BMC Microbiol., 23.","DOI":"10.1186\/s12866-023-02881-2"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Abdelrahman, F., Easwaran, M., Daramola, O.I., Ragab, S., Lynch, S., Oduselu, T.J., Khan, F.M., Ayobami, A., Adnan, F., and Torrents, E. (2021). Phage-Encoded Endolysins. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020124"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Mayorga-Ramos, A., Carrera-Pacheco, S.E., Barba-Ostria, C., and Guam\u00e1n, L.P. (2024). Bacteriophage-Mediated Approaches for Biofilm Control. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1428637"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2273567","DOI":"10.1080\/21505594.2023.2273567","article-title":"Potential of Phage Depolymerase for the Treatment of Bacterial Biofilms","volume":"14","author":"Guo","year":"2023","journal-title":"Virulence"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Dicks, L.M.T., and Vermeulen, W. (2024). Bacteriophage-Host Interactions and the Therapeutic Potential of Bacteriophages. Viruses, 16.","DOI":"10.3390\/v16030478"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12934-024-02359-4","article-title":"LysSYL: A Broad-Spectrum Phage Endolysin Targeting Staphylococcus Species and Eradicating S. Aureus Biofilms","volume":"23","author":"Liu","year":"2024","journal-title":"Microb. Cell Fact."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Liu, H., Hu, Z., Li, M., Yang, Y., Lu, S., and Rao, X. (2023). Therapeutic Potential of Bacteriophage Endolysins for Infections Caused by Gram-Positive Bacteria. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00919-1"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.copbio.2021.02.002","article-title":"Targeting Biofilms Using Phages and Their Enzymes","volume":"68","author":"Azeredo","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Topka-Bielecka, G., Dydecka, A., Necel, A., Bloch, S., Nejman-Fale\u0144czyk, B., W\u0119grzyn, G., and W\u0119grzyn, A. (2021). Bacteriophage-Derived Depolymerases against Bacterial Biofilm. Antibiotics, 10.","DOI":"10.3390\/antibiotics10020175"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Wang, J., Liang, S., Lu, X., Xu, Q., Zhu, Y., Yu, S., Zhang, W., Liu, S., and Xie, F. (2023). Bacteriophage Endolysin Ply113 as a Potent Antibacterial Agent against Polymicrobial Biofilms Formed by Enterococci and Staphylococcus Aureus. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1304932"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Lu, R., Liu, B., Wu, L., Bao, H., Garc\u00eda, P., Wang, Y., Zhou, Y., and Zhang, H. (2023). A Broad-Spectrum Phage Endolysin (LysCP28) Able to Remove Biofilms and Inactivate Clostridium Perfringens Strains. Foods, 12.","DOI":"10.3390\/foods12020411"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Castro, J., Sousa, L.G.V., Fran\u00e7a, \u00c2., Podpera Tisakova, L., Corsini, L., and Cerca, N. (2022). Exploiting the Anti-Biofilm Effect of the Engineered Phage Endolysin PM-477 to Disrupt In Vitro Single- and Dual-Species Biofilms of Vaginal Pathogens Associated with Bacterial Vaginosis. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050558"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez, D., Briers, Y., Rodr\u00edguez-Rubio, L., Mart\u00ednez, B., Rodr\u00edguez, A., Lavigne, R., and Garc\u00eda, P. (2015). Role of the Pre-Neck Appendage Protein (Dpo7) from Phage VB_SepiS-PhiIPLA7 as an Anti-Biofilm Agent in Staphylococcal Species. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.01315"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Shahed-Al-Mahmud, M., Roy, R., Sugiokto, F.G., Islam, M.N., Lin, M.-D., Lin, L.-C., and Lin, N.-T. (2021). Phage \u03a6AB6-Borne Depolymerase Combats Acinetobacter baumannii Biofilm Formation and Infection. Antibiotics, 10.","DOI":"10.3390\/antibiotics10030279"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Wu, Y., Wang, R., Xu, M., Liu, Y., Zhu, X., Qiu, J., Liu, Q., He, P., and Li, Q. (2019). A Novel Polysaccharide Depolymerase Encoded by the Phage SH-KP152226 Confers Specific Activity Against Multidrug-Resistant Klebsiella pneumoniae via Biofilm Degradation. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02768"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/NSA.S325594","article-title":"Bacterial Biofilm Destruction: A Focused Review On The Recent Use of Phage-Based Strategies With Other Antibiofilm Agents","volume":"14","author":"Amankwah","year":"2021","journal-title":"Nanotechnol. Sci. Appl."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1590\/S1517-83822012000100042","article-title":"Characterization and Lytic Activity of Pseudomonas Fluorescens Phages from Sewage","volume":"43","author":"Radhakrishnan","year":"2012","journal-title":"Braz. J. Microbiol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Alexyuk, P., Bogoyavlenskiy, A., Alexyuk, M., Akanova, K., Moldakhanov, Y., and Berezin, V. (2022). Isolation and Characterization of Lytic Bacteriophages Active against Clinical Strains of E. Coli and Development of a Phage Antimicrobial Cocktail. Viruses, 14.","DOI":"10.3390\/v14112381"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/138920110790725401","article-title":"Phage Therapy in Clinical Practice: Treatment of Human Infections","volume":"11","author":"Kutter","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40121-024-01092-0","article-title":"Detection of Phage\u2019s Lytic Activity Against Carbapenemase-Producing Klebsiella pneumoniae Isolates Using a High-Throughput Microbroth Growth Inhibition Assay","volume":"14","author":"Paranos","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Hietala, V., Horsma-Heikkinen, J., Carron, A., Skurnik, M., and Kiljunen, S. (2019). The Removal of Endo- and Enterotoxins From Bacteriophage Preparations. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.01674"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Liu, D., Van Belleghem, J.D., de Vries, C.R., Burgener, E., Chen, Q., Manasherob, R., Aronson, J.R., Amanatullah, D.F., Tamma, P., and Suh, G.A. (2021). The Safety and Toxicity of Phage Therapy: A Review of Pre-Clinical and Clinical Studies. Viruses, 13.","DOI":"10.20944\/preprints202105.0231.v1"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Taha, O.A., Connerton, P.L., Connerton, I.F., and El-Shibiny, A. (2018). Bacteriophage ZCKP1: A Potential Treatment for Klebsiella pneumoniae Isolated From Diabetic Foot Patients. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.02127"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Hitchcock, N.M., Devequi Gomes Nunes, D., Shiach, J., Valeria Saraiva Hodel, K., Dantas Viana Barbosa, J., Alencar Pereira Rodrigues, L., Coler, B.S., Botelho Pereira Soares, M., and Badar\u00f3, R. (2023). Current Clinical Landscape and Global Potential of Bacteriophage Therapy. Viruses, 15.","DOI":"10.3390\/v15041020"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Febvre, H.P., Rao, S., Gindin, M., Goodwin, N.D.M., Finer, E., Vivanco, J.S., Lu, S., Manter, D.K., Wallace, T.C., and Weir, T.L. (2019). PHAGE Study: Effects of Supplemental Bacteriophage Intake on Inflammation and Gut Microbiota in Healthy Adults. Nutrients, 11.","DOI":"10.3390\/nu11030666"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Mu, A., McDonald, D., Jarmusch, A.K., Martino, C., Brennan, C., Bryant, M., Humphrey, G.C., Toronczak, J., Schwartz, T., and Nguyen, D. (2021). Assessment of the Microbiome during Bacteriophage Therapy in Combination with Systemic Antibiotics to Treat a Case of Staphylococcal Device Infection. Microbiome, 9.","DOI":"10.1186\/s40168-021-01026-9"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Torkashvand, N., Kamyab, H., Aarabi, P., Shahverdi, A.R., Torshizi, M.A.K., Khoshayand, M.R., and Sepehrizadeh, Z. (2024). Evaluating the Effectiveness and Safety of a Novel Phage Cocktail as a Biocontrol of Salmonella in Biofilm, Food Products, and Broiler Chicken. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1505805"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Bull, J.J., Wichman, H.A., Krone, S.M., and Molineux, I.J. (2024). Controlling Recombination to Evolve Bacteriophages. Cells, 13.","DOI":"10.3390\/cells13070585"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Bull, J.J., Levin, B.R., and Molineux, I.J. (2019). Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy. Viruses, 11.","DOI":"10.1101\/816678"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Bozidis, P., Markou, E., Gouni, A., and Gartzonika, K. (2024). Does Phage Therapy Need a Pan-Phage?. Pathogens, 13.","DOI":"10.3390\/pathogens13060522"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Oechslin, F. (2018). Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy. Viruses, 10.","DOI":"10.3390\/v10070351"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Liu, S., Lu, H., Zhang, S., Shi, Y., and Chen, Q. (2022). Phages against Pathogenic Bacterial Biofilms and Biofilm-Based Infections: A Review. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14020427"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Br\u00e1s, A., Braz, M., Martinho, I., Duarte, J., Pereira, C., and Almeida, A. (2024). Effect of Bacteriophages against Biofilms of Escherichia Coli on Food Processing Surfaces. Microorganisms, 12.","DOI":"10.20944\/preprints202401.0352.v1"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Tabassum, R., Shafique, M., Khawaja, K.A., Alvi, I.A., Rehman, Y., Sheik, C.S., Abbas, Z., and Rehman, S.u. (2018). Complete Genome Analysis of a Siphoviridae Phage TSK1 Showing Biofilm Removal Potential against Klebsiella pneumoniae. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-36229-y"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10096-023-04649-y","article-title":"A Novel Lytic Phage Exhibiting a Remarkable in Vivo Therapeutic Potential and Higher Antibiofilm Activity against Pseudomonas aeruginosa","volume":"42","author":"Abdelghafar","year":"2023","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.biologicals.2019.10.003","article-title":"Isolation and Characterization of Bacteriophage to Control Multidrug-Resistant Pseudomonas aeruginosa Planktonic Cells and Biofilm","volume":"63","author":"Adnan","year":"2020","journal-title":"Biologicals"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Hakim, T.A., Zaki, B.M., Mohamed, D.A., Blasdel, B., Gad, M.A., Fayez, M.S., and El-Shibiny, A. (2025). Novel Strategies for Vancomycin-Resistant Enterococcus Faecalis Biofilm Control: Bacteriophage (VB_EfaS_ZC1), Propolis, and Their Combined Effects in an Ex Vivo Endodontic Model. Ann. Clin. Microbiol. Antimicrob., 24.","DOI":"10.1186\/s12941-025-00790-y"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2147\/IDR.S348700","article-title":"How Good Are Bacteriophages as an Alternative Therapy to Mitigate Biofilms of Nosocomial Infections","volume":"15","author":"Singh","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Lin, Y., Galgano, S., Houdijk, J., Xie, W., Jin, Y., Lin, J., Song, W., Fu, Y., and Li, X. (2022). Recent Progress in Phage Therapy to Modulate Multidrug-Resistant Acinetobacter baumannii, Including in Human and Poultry. Antibiotics, 11.","DOI":"10.3390\/antibiotics11101406"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Ponce Benavente, L., Wagemans, J., Hinkel, D., Aguerri Lajusticia, A., Lavigne, R., Trampuz, A., and Gonzalez Moreno, M. (2024). Targeted Enhancement of Bacteriophage Activity against Antibiotic-Resistant Staphylococcus Aureus Biofilms through an Evolutionary Assay. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1372325"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Kr\u00f3likowska, D., Szyma\u0144ska, M., Krzy\u017caniak, M., Guzi\u0144ski, A., Matusiak, R., Kajdanek, A., Kaczorek-\u0141ukowska, E., Maszewska, A., W\u00f3jcik, E.A., and Dastych, J. (2024). A New Approach for Phage Cocktail Design in the Example of Anti-Mastitis Solution. Pathogens, 13.","DOI":"10.3390\/pathogens13100839"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Islam, M.M., Mahbub, N.U., Shin, W.S., and Oh, M.H. (2024). Phage-Encoded Depolymerases as a Strategy for Combating Multidrug-Resistant Acinetobacter baumannii. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1462620"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/jam.15421","article-title":"Bacteriophages: A Weapon against Mixed-Species Biofilms in the Food Processing Environment","volume":"133","author":"Mgomi","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Ferriol-Gonz\u00e1lez, C., and Domingo-Calap, P. (2020). Phages for Biofilm Removal. Antibiotics, 9.","DOI":"10.3390\/antibiotics9050268"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/eva.13518","article-title":"Comparison of Bacterial Suppression by Phage Cocktails, Dual-receptor Generalists, and Coevolutionarily Trained Phages","volume":"16","author":"Borin","year":"2023","journal-title":"Evol. Appl."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Yang, Y., Shen, W., Zhong, Q., Chen, Q., He, X., Baker, J.L., Xiong, K., Jin, X., Wang, J., and Hu, F. (2020). Development of a Bacteriophage Cocktail to Constrain the Emergence of Phage-Resistant Pseudomonas aeruginosa. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00327"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"8572","DOI":"10.1038\/s41467-024-52595-w","article-title":"Targeting Pseudomonas aeruginosa Biofilm with an Evolutionary Trained Bacteriophage Cocktail Exploiting Phage Resistance Trade-Offs","volume":"15","author":"Kunisch","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Gao, D., Ji, H., Wang, L., Li, X., Hu, D., Zhao, J., Wang, S., Tao, P., Li, X., and Qian, P. (2022). Fitness Trade-Offs in Phage Cocktail-Resistant Salmonella Enterica Serovar Enteritidis Results in Increased Antibiotic Susceptibility and Reduced Virulence. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.02914-22"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"198496","DOI":"10.1016\/j.virusres.2021.198496","article-title":"Bacteriophage Cocktail and Phage Antibiotic Synergism as Promising Alternatives to Conventional Antibiotics for the Control of Multi-Drug-Resistant Uropathogenic Escherichia Coli","volume":"302","author":"Malik","year":"2021","journal-title":"Virus Res."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Vashisth, M., Jaglan, A.B., Yashveer, S., Sharma, P., Bardajatya, P., Virmani, N., Bera, B.C., Vaid, R.K., and Anand, T. (2023). Development and Evaluation of Bacteriophage Cocktail to Eradicate Biofilms Formed by an Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa. Viruses, 15.","DOI":"10.3390\/v15020427"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/molbev\/msab044","article-title":"Causes and Consequences of Bacteriophage Diversification via Genetic Exchanges across Lifestyles and Bacterial Taxa","volume":"38","author":"Pfeifer","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"jiw632","DOI":"10.1093\/infdis\/jiw632","article-title":"Synergistic Interaction between Phage Therapy and Antibiotics Clears Pseudomonas aeruginosa Infection in Endocarditis and Reduces Virulence","volume":"215","author":"Oechslin","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"G\u00f3rniak, M., Zalewska, A., and Jurczak-Kurek, A. (2022). Recombination Events in Putative Tail Fibre Gene in Litunavirus Phages Infecting Pseudomonas aeruginosa and Their Phylogenetic Consequences. Viruses, 14.","DOI":"10.3390\/v14122669"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e0192321","DOI":"10.1128\/aac.01923-21","article-title":"Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host","volume":"66","author":"Blasco","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Yang, Q., Le, S., Zhu, T., and Wu, N. (2023). Regulations of Phage Therapy across the World. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1250848"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"109172","DOI":"10.1016\/j.celrep.2021.109172","article-title":"Temperate Phage-Antibiotic Synergy Eradicates Bacteria through Depletion of Lysogens","volume":"35","author":"Fatima","year":"2021","journal-title":"Cell Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1093\/jac\/dkae203","article-title":"Penicillin-Binding Protein 3 Sequence Variations Reduce Susceptibility of Pseudomonas aeruginosa to \u03b2-Lactams but Inhibit Cell Division","volume":"79","author":"Glen","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2958.2007.06069.x","article-title":"DivS, a Novel SOS-inducible Cell-division Suppressor in Corynebacterium glutamicum","volume":"67","author":"Ogino","year":"2008","journal-title":"Mol. Microbiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/AAC.02487-19","article-title":"A Roadblock-and-Kill Mechanism of Action Model for the DNA-Targeting Antibiotic Ciprofloxacin","volume":"64","author":"Ojkic","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/AAC.00892-06","article-title":"Sublethal Concentrations of the Aminoglycoside Amikacin Interfere with Cell Division without Affecting Chromosome Dynamics","volume":"51","author":"Possoz","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Supina, B.S.I., and Dennis, J.J. (2025). The Current Landscape of Phage\u2013Antibiotic Synergistic (PAS) Interactions. Antibiotics, 14.","DOI":"10.3390\/antibiotics14060545"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Bulssico, J., PapukashvilI, I., Espinosa, L., Gandon, S., and Ansaldi, M. (2023). Phage-Antibiotic Synergy: Cell Filamentation Is a Key Driver of Successful Phage Predation. PLoS Pathog., 19.","DOI":"10.1371\/journal.ppat.1011602"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e0060724","DOI":"10.1128\/msystems.00607-24","article-title":"Antibacterial Effect of Phage Cocktails and Phage-Antibiotic Synergy against Pathogenic Klebsiella Pneumoniae","volume":"9","author":"Zhao","year":"2024","journal-title":"mSystems"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e01462-20","DOI":"10.1128\/mBio.01462-20","article-title":"Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry","volume":"11","author":"Green","year":"2020","journal-title":"mBio"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Morris, T.C., Reyneke, B., Khan, S., and Khan, W. (2025). Phage-Antibiotic Synergy to Combat Multidrug Resistant Strains of Gram-Negative ESKAPE Pathogens. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-01489-y"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Karthika, C., Malligarjunan, N., Hari Prasath, N., Karutha Pandian, S., and Gowrishankar, S. (2025). Phage (Cocktail)-Antibiotic Synergism: A New Frontier in Addressing Klebsiella pneumoniae Resistance. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1588472"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Lin, L.-C., Tsai, Y.-C., and Lin, N.-T. (2025). Phage\u2013Antibiotic Synergy Enhances Biofilm Eradication and Survival in a Zebrafish Model of Pseudomonas aeruginosa Infection. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115337"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"107590","DOI":"10.1016\/j.ijid.2024.107590","article-title":"Exploring Phage-Antibiotic Synergies in The Context of Biofilm-Related Infectious Diseases","volume":"152","author":"Kumarudin","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1139\/cjm-2022-0080","article-title":"Synergy of a Virulent Phage (\u03a6AB182) with Antibiotics Leading to Successful Elimination of Biofilms Formed by MDR Acinetobacter baumannii","volume":"68","author":"Vashisth","year":"2022","journal-title":"Can. J. Microbiol."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Kunz Coyne, A.J., Stamper, K., Bleick, C., Kebriaei, R., Lehman, S.M., and Rybak, M.J. (2024). Synergistic Bactericidal Effects of Phage-Enhanced Antibiotic Therapy against MRSA Biofilms. Microbiol. Spectr., 12.","DOI":"10.1128\/spectrum.03212-23"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Lev, K., Kunz Coyne, A.J., Kebriaei, R., Morrisette, T., Stamper, K., Holger, D.J., Canfield, G.S., Duerkop, B.A., Arias, C.A., and Rybak, M.J. (2022). Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus Faecium. Antibiotics, 11.","DOI":"10.3390\/antibiotics11030392"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/IDR.S402962","article-title":"Advance on Engineering of Bacteriophages by Synthetic Biology","volume":"16","author":"Sun","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Mion, S., R\u00e9my, B., Plener, L., Br\u00e9geon, F., Chabri\u00e8re, E., and Daud\u00e9, D. (2019). Quorum Quenching Lactonase Strengthens Bacteriophage and Antibiotic Arsenal Against Pseudomonas aeruginosa Clinical Isolates. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02049"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.archoralbio.2016.07.001","article-title":"Effect of a Genetically Engineered Bacteriophage on Enterococcus Faecalis Biofilms","volume":"71","author":"Tinoco","year":"2016","journal-title":"Arch. Oral. Biol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40259-021-00480-z","article-title":"Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future","volume":"35","year":"2021","journal-title":"BioDrugs"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Steczynska, J.P., Kerr, S.J., Kelly, M.L., Whittle, M.J., Bilverstone, T.W., and Minton, N.P. (2023). A Tale of Two Phage Tails: Engineering the Host Range of Bacteriophages Infecting Clostridioides difficile. bioRxiv, bioRxiv:2023.10.16.562632.","DOI":"10.1101\/2023.10.16.562632"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e1096995","DOI":"10.1080\/21597081.2015.1096995","article-title":"Development of Expanded Host Range Phage Active on Biofilms of Multi-Drug Resistant Pseudomonas aeruginosa","volume":"6","author":"Mapes","year":"2016","journal-title":"Bacteriophage"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.apsb.2023.08.017","article-title":"Translating Bacteriophage-Derived Depolymerases into Antibacterial Therapeutics: Challenges and Prospects","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Khan, F.M., Chen, J.-H., Zhang, R., and Liu, B. (2023). A Comprehensive Review of the Applications of Bacteriophage-Derived Endolysins for Foodborne Bacterial Pathogens and Food Safety: Recent Advances, Challenges, and Future Perspective. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1259210"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Chung, K.M., Liau, X.L., and Tang, S.S. (2023). Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment. Pharmaceuticals, 16.","DOI":"10.3390\/ph16101467"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Fatima, R., and Hynes, A.P. (2025). Phage-Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected. Microb. Biotechnol., 18.","DOI":"10.1111\/1751-7915.70193"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e34333","DOI":"10.1016\/j.heliyon.2024.e34333","article-title":"Engineered Bacteriophages: A Panacea against Pathogenic and Drug Resistant Bacteria","volume":"10","author":"Kakkar","year":"2024","journal-title":"Heliyon"},{"key":"ref_160","unstructured":"Ruedelsheim, P.L.J., Smets, G., Van Der Meulen, K., and Van Rooij, P. (2025, July 24). Advances in the Application of GM Phages in Research, Development and Industry, Final COGEM Report CGM 2024-02 2024. Available online: https:\/\/cogem.net\/en\/publication\/advances-in-the-application-of-gm-phages-in-research-development-and-industry\/."},{"key":"ref_161","unstructured":"ClinicalTrials.Gov (2025, July 24). Search Results for \u201cBacteriophage Therapy\u201d; Identifier List Accessed via ClinicalTrials.Gov, Available online: Https:\/\/Clinicaltrials.Gov\/Search?Intr=Bacteriophage%20Therapy&page=3."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Latka, A., and Drulis-Kawa, Z. (2020). Advantages and Limitations of Microtiter Biofilm Assays in the Model of Antibiofilm Activity of Klebsiella Phage KP34 and Its Depolymerase. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-77198-5"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12985-020-01485-w","article-title":"Characterization of Four Virulent Klebsiella pneumoniae Bacteriophages, and Evaluation of Their Potential Use in Complex Phage Preparation","volume":"18","author":"Zurabov","year":"2021","journal-title":"Virol. J."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Asghar, S., Ahmed, A., Khan, S., Lail, A., and Shakeel, M. (2022). Genomic Characterization of Lytic Bacteriophages A\u00a5L and A\u00a5M Infecting ESBL K. Pneumoniae and Its Therapeutic Potential on Biofilm Dispersal and in-Vivo Bacterial Clearance. Microbiol. Res., 262.","DOI":"10.1016\/j.micres.2022.127104"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Wintachai, P., Surachat, K., Chaimaha, G., Septama, A.W., and Smith, D.R. (2022). Isolation and Characterization of a Phapecoctavirus Infecting Multidrug-Resistant Acinetobacter baumannii in A549 Alveolar Epithelial Cells. Viruses, 14.","DOI":"10.3390\/v14112561"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"106064","DOI":"10.1016\/j.micpath.2023.106064","article-title":"Phage-Based Therapy against Biofilm Producers in Gram-Negative ESKAPE Pathogens","volume":"178","author":"Ragupathi","year":"2023","journal-title":"Microb. Pathog."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Kovacs, C.J., Rapp, E.M., Rankin, W.R., McKenzie, S.M., Brasko, B.K., Hebert, K.E., Bachert, B.A., Kick, A.R., Burpo, F.J., and Barnhill, J.C. (2024). Combinations of Bacteriophage Are Efficacious against Multidrug-Resistant Pseudomonas aeruginosa and Enhance Sensitivity to Carbapenem Antibiotics. Viruses, 16.","DOI":"10.3390\/v16071000"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Gu\u0142a, G., Majkowska-Skrobek, G., Misterkiewicz, A., Salwi\u0144ska, W., Piasecki, T., and Drulis-Kawa, Z. (2025). Klebsiella Lytic Phages Induce Pseudomonas aeruginosa PAO1 Biofilm Formation. Viruses, 17.","DOI":"10.3390\/v17050615"},{"key":"ref_169","unstructured":"(2025). Orthopaedic Innovation Centre Phage Therapy for the Treatment of a Chronic Enterococcus Faecium Periprosthetic Joint Infection (Standard No. NCT06942624)."},{"key":"ref_170","unstructured":"(2024). University of Calgary Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection (Standard No. NCT06456424)."},{"key":"ref_171","unstructured":"(2025). Ottawa Hospital Research Institute Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas aeruginosa (Standard No. NCT06798168)."},{"key":"ref_172","unstructured":"(2025). Phaxiam Therapeutics A Phase II Proof of Concept Multicenter, Randomized, Double-Blind Study to Assess the Safety and Efficacy of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus Aureus Treated by DAIR (Standard No. NCT06605651)."},{"key":"ref_173","unstructured":"(2022). Randomized Open Label, Parallel Group, Controlled Study to Evaluate the Safety and Surgery Sparing Effect of Phage Therapy with Antibiotics for Patients with Prosthetic Joint Infections Who Are Candidates for Two Stage Exchange Arthroplasty (Standard No. NCT04787250)."},{"key":"ref_174","unstructured":"(2022). An Open-Label Multicenter Study to Evaluate the Safety and Efficacy of PhageBankTM Phage Therapy in Conjunction With Debridement, Antibiotics, and Implant Retention (DAIR) for Patients with First Time Culture Proven Chronic Prosthetic Joint Infection (Standard No. NCT05269121)."},{"key":"ref_175","unstructured":"(2023). A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of APT Phage Bank Phage Therapy Versus Placebo in Conjunction with Debridement, Antibiotics, and Implant Retention (DAIR) in Subjects with Chronic Prosthetic Joint Infection (PJI) (Standard No. NCT05269134)."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8699\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:41:18Z","timestamp":1760035278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":175,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178699"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178699","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,6]]}}}